Stocks and Investing
Stocks and Investing
Wed, August 23, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, August 22, 2017
[ 12:00 AM ] - United States, WOPRAI
Mon, August 21, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ana Gupte Maintained (THC) at Buy with Increased Target to $30 on, Aug 21st, 2017
Ana Gupte of Leerink Swann, Maintained "Tenet Healthcare Corporation" (THC) at Buy with Increased Target from $23 to $30 on, Aug 21st, 2017.
Ana has made no other calls on THC in the last 4 months.
There are 4 other peers that have a rating on THC. Out of the 4 peers that are also analyzing THC, 2 agree with Ana's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Scott Fidel of "Credit Suisse" Maintained at Hold with Decreased Target to $17 on, Wednesday, August 9th, 2017
- Andrew Schenker of "Morgan Stanley" Initiated at Hold and Held Target at $19 on, Wednesday, June 7th, 2017
These are the ratings of the 2 analyists that currently disagree with Ana
- Christopher Rigg of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $24 on, Thursday, August 10th, 2017
- Gary Lieberman of "Wells Fargo" Upgraded from Hold to Buy on, Tuesday, June 6th, 2017